DRUG · Mapped RxNorm record
Dulaglutide
Normalized identity: dulaglutideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
NCT04591626
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Insulin Glargine
Normalized identity: insulin glargineView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
DulaglutideDRUG · verified · RxNorm: dulaglutide
PlaceboDRUG
Insulin GlargineDRUG · verified · RxNorm: insulin glargine
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04591626 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.